CXCR4 and breast cancer: This was further substantiated by decreased bone metastasis of breast cancer (Huppert et al., 2022) cells upon inhibition of CXCL12/CXCR4 axis and indoleamine 2,3-dioxygenase (IDO1) expression (Huppert et al., 2022).